Showing results (641-650 of 712) with videos related to

Sort By:
Pageof 72
Science Translational Medicine|July 16, 2010
Quinone oxidoreductase-2-mediated prodrug cancer therapyMark R Middleton, Richard Knox, Emma Cattell, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2026
Anhedonia buffers the effects of early-life unpredictability on threat-reward decision-makingBianca T Leonard, Maria Alejandra Martinez-Ortiz, Jason Bock, et al.
Development and Psychopathology|January 17, 2022
Neural effects of controllability as a key dimension of stress exposureEmily M Cohodes, Paola Odriozola, Jeffrey D Mandell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 7, 2006
A phase I study of single administration of antibody-directed enzyme prodrug therapy with the recombinant anti-carcinoembryonic antigen antibody-enzyme fusion protein MFECP1 and a bis-iodo phenol mustard prodrugAstrid Mayer, Roslyn J Francis, Surinder K Sharma, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|November 1, 2016
A novel accelerometer-based method to describe day-to-day exposure to potentially osteogenic vertical impacts in older adults: findings from a multi-cohort studyK Hannam, K C Deere, A Hartley, et al.
Scientific Reports|June 17, 2015
A G-quadruplex-binding compound showing anti-tumour activity in an in vivo model for pancreatic cancerStephan A Ohnmacht, Chiara Marchetti, Mekala Gunaratnam, et al.
Proteomics. Clinical Applications|April 12, 2014
Quantification of peptides from immunoglobulin constant and variable regions by LC-MRM MS for assessment of multiple myeloma patientsElizabeth R Remily-Wood, Kaaron Benson, Rachid C Baz, et al.
Endocrine-Related Cancer|July 19, 2021
Whole-genome sequencing of single circulating tumor cells from neuroendocrine neoplasmsAlexa Childs, Christopher D Steele, Clare Vesely, et al.
Pageof 72